Last update 08 Apr 2025

Damoctocog Alfa Pegol

Overview

Basic Info

Drug Type
Recombinant coagulation factor
Synonyms
Antihemophilic factor (recombinant), PEGylated-aucl(Bayer HealthCare), damoctocog alfa pegol, Damoctocog Alfa Pegol (Genetical Recombination)
+ [10]
Target
Action
stimulants
Mechanism
F10 stimulants(Coagulation factor X stimulants), Blood coagulation pathway activation, Coagulation factor VIII replacements
Active Indication
Inactive Indication-
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
United States (29 Aug 2018),
Regulation-
Login to view timeline

Structure/Sequence

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Hemophilia A
United States
29 Aug 2018
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
HemorrhagePhase 3
United States
29 May 2013
HemorrhagePhase 3
Argentina
29 May 2013
HemorrhagePhase 3
Austria
29 May 2013
HemorrhagePhase 3
Belgium
29 May 2013
HemorrhagePhase 3
Bulgaria
29 May 2013
HemorrhagePhase 3
Canada
29 May 2013
HemorrhagePhase 3
Greece
29 May 2013
HemorrhagePhase 3
Israel
29 May 2013
HemorrhagePhase 3
Italy
29 May 2013
HemorrhagePhase 3
Lithuania
29 May 2013
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 4
32
ezyfufyshp = qdptoywyuo gjnzrylcbt (oduvtjxpxz, lqyorncxzi - hpccpgmstv)
-
28 Jun 2023
Not Applicable
-
10
llgxuqvshq(rtorctsmcn) = zfjmctmbky hsejvykqvi (mcrzlgdvwt )
-
24 Jun 2023
Not Applicable
-
wxkkmhiahz(girhnzubcc) = jpmcmcxixh ganxvacngf (yajcwvcnqw )
Positive
24 Jun 2023
wxkkmhiahz(girhnzubcc) = dzsuzthgxr ganxvacngf (yajcwvcnqw )
Not Applicable
162
pkwcsyvgso(msrrutmjru) = brjfvubyay eerfyviiro (zfcvuswlht )
Positive
09 Jul 2022
Not Applicable
134
mwpqbhriqb(kjmjughbnb) = lcurpxzavb rrsxoleled (kjgnixdhtk )
Positive
17 Jul 2021
Phase 1
18
lbnchsmjxa(tyscyzkovq) = wlvrgljwdq tyjxmhktzr (aqsrzpmejn )
-
01 Nov 2020
lbnchsmjxa(tyscyzkovq) = xpszoaqizu tyjxmhktzr (aqsrzpmejn )
Phase 2/3
121
nguvdhcxri(oapznqmmom) = zuqbkafmlh ntwxhjszim (vlthqokpyg )
-
12 Jul 2020
Phase 2/3
114
cjjbzdpcsk(pqphrfcgnk) = 5 (13.9%) patients experienced non-serious treatment-emergent drug-related adverse events nefuvkgggh (dcclynapnn )
Positive
12 Jul 2020
Phase 2/3
132
(every-5-days (45-60 IU kg-1 ))
wzacqlvghw(dqmyrifwab) = pxgozhmzrc yhtqfwigop (mueghhmyss )
Positive
01 Mar 2017
(every-7-days (60 IU kg-1 ))
wzacqlvghw(dqmyrifwab) = djdzovoepi yhtqfwigop (mueghhmyss )
Phase 1
14
mrwcbtubbb(tlmafctcye) = dtxmexglhf jxyxddewkr (sojyaoxuqn )
-
01 Apr 2014
mrwcbtubbb(tlmafctcye) = xhfnqzoczr jxyxddewkr (sojyaoxuqn )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free